Mechanism mediating oligomeric Aβ clearance by naïve primary microglia

Neurobiology of Disease

Volumn 42, Issue 3, 2011, Pages 221-230

  Yang, Cheng Ning ^a   Shiao, Young Ji ^b   Shie, Feng Shiun ^c   Guo, Bo Shen ^a   Chen, Pei Hao ^d   Cho, Chi Yuan ^a   Chen, Yi Jen ^a   Huang, Fong Lee ^a   Tsay, Huey Jen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Alzheimer's disease; Beta amyloid; Lysosomal degradation; Scavenger receptors

Indexed keywords

AMYLOID BETA PROTEIN; CATHEPSIN B; CD36 ANTIGEN; CYSTEINE PROTEINASE; INSULINASE; MATRIX METALLOPROTEINASE; MEMBRANE METALLOENDOPEPTIDASE; NEUTRALIZING ANTIBODY; PROTEINASE; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A; SMALL INTERFERING RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL LYSATE; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; CULTURE MEDIUM; IMMUNOPRECIPITATION; INCUBATION TEMPERATURE; INTERNALIZATION; LYSOSOME; MEMORY DISORDER; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN TRANSPORT; SENILE PLAQUE; ULTRACENTRIFUGATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; INSULYSIN; LYSOSOMES; MICE; MICROGLIA; NEPRILYSIN; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, SCAVENGER; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 79954632126     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.01.005     Document Type: Article

References (52)

1. Barrachina M., et al. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 2006, 32:505-516.
2. Blennow K., et al. Alzheimer's disease. Lancet 2006, 368:387-403.
3. Block M.L., et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
4. Brown P.H., Schuck P. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys. J. 2006, 90:4651-4661.
5. Chou C.Y., et al. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution. Biophys. J. 2005, 88:455-466.
6. Chromy B.A., et al. Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 2003, 42:12749-12760.
7. Chung H., et al. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J. Biol. Chem. 1999, 274:32301-32308.
8. Cooper A., Shaul Y. Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles. J. Biol. Chem. 2006, 281:16563-16569.
9. Coraci I.S., et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 2002, 160:101-112.
10. Dahlgren K.N., et al. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 2002, 277:32046-32053.
11. El Khoury J., et al. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 1996, 382:716-719.
12. Feng F.Y., et al. Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. Oncogene 2007, 26:3431-3439.
13. Graves A.R., et al. The Cl-/H+antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 2008, 453:788-792.
14. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
15. Hu X., et al. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl Acad. Sci. USA 2009, 106:20324-20329.
16. Huang W.C., et al. Enlargement of Abeta aggregates through chemokine-dependent microglial clustering. Neurosci. Res. 2009, 63:280-287.
17. Husemann J., et al. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002, 40:195-205.
18. Jiang Q., et al. ApoE promotes the proteolytic degradation of Abeta. Neuron 2008, 58:681-693.
19. Klyubin I., et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 2005, 11:556-561.
20. Lee H.J., et al. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem. Biophys. Res. Commun. 2008, 372:423-428.
21. Lesne S., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
22. Longva K.E., et al. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 2002, 156:843-854.
23. Majumdar A., et al. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell 2007, 18:1490-1496.
24. Mandrekar S., et al. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J. Neurosci. 2009, 29:4252-4262.
25. Marques C., et al. Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells. FASEB J. 2004, 18:1424-1426.
26. Meilandt W.J., et al. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J. Neurosci. 2009, 29:1977-1986.
27. Moore K.J., Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1702-1711.
28. Mueller-Steiner S., et al. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 2006, 51:703-714.
29. Nakamura Y., et al. Lysosome instability in aged rat brain. Neurosci. Lett. 1989, 97:215-220.
30. Nakanishi H., Wu Z. Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging. Behav. Brain Res. 2009, 201:1-7.
31. Nishi T., Forgac M. The vacuolar (H+)-ATPases-nature's most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 2002, 3:94-103.
32. Ono K., et al. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc. Natl Acad. Sci. USA 2009, 106:14745-14750.
33. Paresce D.M., et al. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 1996, 17:553-565.
34. Parvathy S., et al. Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells 2008, Neurobiol Aging.
35. Roychaudhuri R., et al. Amyloid beta-protein assembly and Alzheimer disease. J. Biol. Chem. 2009, 284:4749-4753.
36. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 2000, 78:1606-1619.
37. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron 2001, 32:177-180.
38. Shankar G.M., et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
39. Shie F.S., et al. Microglia lacking E prostanoid receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity. Am. J. Pathol. 2005, 166:1163-1172.
40. Shimizu E., et al. IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia. J. Immunol. 2008, 181:6503-6513.
41. Sondag C.M., et al. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J. Neuroinflammation 2009, 6:1.
42. Stine W.B., et al. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 2003, 278:11612-11622.
43. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006, 29:506-510.
44. Streit W.J., Xue Q.S. Life and death of microglia. J. Neuroimmune Pharmacol. 2009, 4:371-379.
45. Sun B., et al. Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 2008, 60:247-257.
46. Tahara K., et al. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129:3006-3019.
47. Townsend M., et al. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 2006, 572:477-492.
48. Walsh D.M., Selkoe D.J. A beta oligomers-a decade of discovery. J. Neurochem. 2007, 101:1172-1184.
49. Wang C.N., et al. Degradation of apolipoprotein B in cultured rat hepatocytes occurs in a post-endoplasmic reticulum compartment. J. Biol. Chem. 1995, 270:24924-24931.
50. Wang Y.J., et al. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives. Drug Discov. Today 2006, 11:931-938.
51. Yamasaki R., et al. Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice. Mol. Cell. Neurosci. 2007, 35:573-584.
52. Yang A.J., et al. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J. Neurosci. Res. 1998, 52:691-698.